ASX - Delayed Quote AUD
Cynata Therapeutics Limited (CYP.AX)
0.2000
0.0000
(0.00%)
As of 10:05:43 AM GMT+10. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | -0.05 | -0.01 |
| Low Estimate | 0 | 0 | -0.05 | -0.01 |
| High Estimate | 0 | 0 | -0.05 | -0.01 |
| Year Ago EPS | -- | -- | -0.05 | -0.05 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 900k | 7.2M |
| Low Estimate | -- | -- | 900k | 7.2M |
| High Estimate | -- | -- | 900k | 7.2M |
| Year Ago Sales | -- | -- | 2.32M | 900k |
| Sales Growth (year/est) | -- | -- | -61.13% | 700.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.05 | -0.01 |
| 7 Days Ago | 0 | 0 | -0.05 | -0.01 |
| 30 Days Ago | 0 | 0 | -0.05 | -0.01 |
| 60 Days Ago | 0 | 0 | -0.05 | -0.01 |
| 90 Days Ago | 0 | 0 | -0.05 | -0.01 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CYP.AX | -- | -- | 15.13% | 80.43% |
| S&P 500 | 13.31% | 2.67% | 7.78% | 13.74% |
Related Tickers
OPT.AX Opthea Limited
0.6000
0.00%
ATHXQ Athersys, Inc.
0.0000
0.00%
RAC.AX Race Oncology Limited
1.4150
-2.08%
PAR.AX Paradigm Biopharmaceuticals Limited
0.3200
-3.03%
CU6.AX Clarity Pharmaceuticals Ltd
2.2700
-9.20%
DXB.AX Dimerix Limited
0.5800
-2.52%
OCC.AX Orthocell Limited
1.2300
-3.53%
MSB.AX Mesoblast Limited
1.7250
-0.29%
NEU.AX Neuren Pharmaceuticals Limited
12.82
-2.81%
BRTX BioRestorative Therapies, Inc.
1.6100
-3.59%